PortalPublikationenQuality of life of patients receiving platinum-based chemoth...

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Links

  • R Mesía
  • F Rivera
  • A Kawecki
  • S Rottey
  • R Hitt
  • H Kienzer
  • D Cupissol
  • D De Raucourt
  • M Benasso
  • P Koralewski
  • J-P Delord
  • Carsten Bokemeyer
  • D Curran
  • A Gross
  • J B Vermorken

Beteiligte Einrichtungen

Abstract

A phase III trial demonstrated that cetuximab is the first agent in 30 years to improve survival when added to platinum-based chemotherapy (platinum-fluorouracil) first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). This analysis of the trial assessed the impact of treatment on quality of life (QoL).

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer10
ISSN0923-7534
StatusVeröffentlicht - 2010
pubmed 20335368